Endothelium-dependent delivery of insulin to muscle interstitium.
Cell Metab., Mar;13(3):236-8 (2011)
Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice.
Cell Metab., May;11(5):379-89 (2010)
Glomerular-specific protein kinase C-Î²-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity.
Kidney Int., Apr;79(8):883-96 (2011)
PKCÎ´ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans.
J. Clin. Invest., Jun;121(6):2504-17 (2011)
Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation: novel mechanism for PPARgamma agonist's effects on edema and weight gain.
FASEB J., Jun;20(8):1203-5 (2006)
Bactericidal/permeability-increasing protein's signaling pathways and its retinal trophic and anti-angiogenic effects.
FASEB J., Oct;20(12):2058-67 (2006)
Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice.
Diabetes., Nov;55(11):3112-20 (2006)
Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: possible contribution to impaired incretin effects in diabetes.
Diabetes., Jun;56(6):1551-8 (2007)
Effects of insulin replacements, inhibitors of angiotensin, and PKCbeta's actions to normalize cardiac gene expression and fuel metabolism in diabetic rats.
Diabetes., May;56(5):1410-20 (2007)
Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study.
Diabetes Care., Aug;30(8):1995-7 (2007)
The role of protein kinase C activation in diabetic nephropathy.
Kidney Int. Suppl., Aug(106):S49-53 (2007)
Glypican 4, a membrane binding protein for bactericidal/permeability-increasing protein signaling pathways in retinal pigment epithelial cells.
Invest. Ophthalmol. Vis. Sci., Dec;48(12):5750-5 (2007)
Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis.
Cell Metab., Feb;7(2):125-34 (2008)
Differential regulation of VEGF signaling by PKC-alpha and PKC-epsilon in endothelial cells.
Arterioscler. Thromb. Vasc. Biol., May;28(5):919-24 (2008)
Selective regulation of heme oxygenase-1 expression and function by insulin through IRS1/phosphoinositide 3-kinase/Akt-2 pathway.
J. Biol. Chem., Dec;283(49):34327-36 (2008)
The role of inflammatory cytokines in diabetes and its complications.
J. Periodontol., Aug;79(8 Suppl):1527-34 (2008)
Insulin regulates SOCS2 expression and the mitogenic effect of IGF-1 in mesangial cells.
Kidney Int., Dec;74(11):1434-43 (2008)
Phosphoinositide 3-kinase Akt signaling pathway interacts with protein kinase Cbeta2 in the regulation of physiologic developmental hypertrophy and heart function.
Am. J. Physiol. Heart Circ. Physiol., Mar;296(3):H566-72 (2009)
Identification of linguistic barriers to diabetes knowledge and glycemic control in Chinese Americans with diabetes.
Diabetes Care., Feb;29(2):415-6 (2006)
Activation of vascular protein kinase C-beta inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance.
Diabetes., Mar;55(3):691-8 (2006)
Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications.
Curr. Diab. Rep., Apr;5(2):91-7 (2005)
Differential regulation of angiotensin II-induced expression of connective tissue growth factor by protein kinase C isoforms in the myocardium.
J. Biol. Chem., Apr;280(16):15719-26 (2005)
Oxidative stress and antioxidant treatment in diabetes.
Ann. N. Y. Acad. Sci., Dec;1031:204-13 (2004)
The effect of vitamin E on endothelial function of micro- and macrocirculation and left ventricular function in type 1 and type 2 diabetic patients.
Diabetes., Jan;54(1):204-11 (2005)
Microvascular complications of diabetes.
Endocrinol. Metab. Clin. North Am., Mar;33(1):215-38, xi-xii (2004)
Oxidative stress: the lead or supporting actor in the pathogenesis of diabetic complications.
J. Am. Soc. Nephrol., Aug;14(8 Suppl 3):S216-20 (2003)
Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization.
J. Clin. Invest., Jun;111(12):1835-42 (2003)
B-cell signaling: protein kinase Cdelta puts the brakes on.
Curr. Biol., Aug;12(16):R554-6 (2002)
Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C beta2 activation and diabetes.
Diabetes., Sep;51(9):2709-18 (2002)
Diacylglycerol production and protein kinase C activity are increased in a mouse model of diabetic embryopathy.
Diabetes., Sep;51(9):2804-10 (2002)
Characterization of retinal leukostasis and hemodynamics in insulin resistance and diabetes: role of oxidants and protein kinase-C activation.
Diabetes., Mar;52(3):829-37 (2003)
Role of protein kinase C on the expression of platelet-derived growth factor and endothelin-1 in the retina of diabetic rats and cultured retinal capillary pericytes.
Diabetes., Mar;52(3):838-45 (2003)
Endothelial dysfunction in diabetes mellitus: role in cardiovascular disease.
Heart Fail Monit., 1(3):74-82 (2001)
Characterization of multiple signaling pathways of insulin in the regulation of vascular endothelial growth factor expression in vascular cells and angiogenesis.
J. Biol. Chem., Aug;278(34):31964-71 (2003)
Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo : a specific vascular action of insulin.
Circulation., Feb;101(6):676-81 (2000)
Identification of PKC-isoform-specific biological actions using pharmacological approaches.
Trends Pharmacol. Sci., May;21(5):181-7 (2000)
Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells.
J. Biol. Chem., Dec;275(52):40725-31 (2000)
von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes.
Diabetes Care., Nov;23(11):1694-8 (2000)
Can VEGF reverse diabetic neuropathy in human subjects?
J. Clin. Invest., May;107(10):1215-8 (2001)
Stretch-induced retinal vascular endothelial growth factor expression is mediated by phosphatidylinositol 3-kinase and protein kinase C (PKC)-zeta but not by stretch-induced ERK1/2, Akt, Ras, or classical/novel PKC pathways.
J. Biol. Chem., Jan;277(2):1047-57 (2002)
Involvement of protein kinase C beta 2 in c-myc induction by high glucose in pancreatic beta-cells.
J. Biol. Chem., Feb;277(5):3680-5 (2002)
Angiotensin AT(1) receptor stimulates heat shock protein 27 phosphorylation in vitro and in vivo.
Hypertension., Dec;38(6):1260-5 (2001)
Characterization of protein kinase C beta isoform's action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization.
Proc. Natl. Acad. Sci. U.S.A., Jan;99(2):721-6 (2002)
Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth.
Invest. Ophthalmol. Vis. Sci., Feb;43(2):503-9 (2002)
Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.
Diabetes., Sep;48(9):1856-62 (1999)
d-Alpha-tocopherol prevents the hyperglycemia induced activation of diacylglycerol (DAG)-protein kinase C (PKC) pathway in vascular smooth muscle cell by an increase of DAG kinase activity.
Diabetes Res. Clin. Pract., Sep;45(2-3):183-90 (1999)
Overexpression of core 2 N-acetylglycosaminyltransferase enhances cytokine actions and induces hypertrophic myocardium in transgenic mice.
FASEB J., Dec;13(15):2329-37 (1999)
Pigment-epithelium-derived factor--a key coordinator of retinal neuronal and vascular functions.
N. Engl. J. Med., Feb;342(5):349-51 (2000)
The role of protein kinase C activation in the pathogenesis of diabetic vascular complications.
Perit Dial Int., 19 Suppl 2:S222-7 (1999)
Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats.
J. Clin. Invest., Aug;104(4):447-57 (1999)
Hyperinsulinemia does not change atherosclerosis development in apolipoprotein E null mice.
Arterioscler. Thromb. Vasc. Biol., May;32(5):1124-31 (2012)
Activation of protein kinase C isoforms and its impact on diabetic complications.
Circ. Res., Apr;106(8):1319-31 (2010)
Modulating Notch signaling to enhance neovascularization and reperfusion in diabetic mice.
Biomaterials., Dec;31(34):9048-56 (2010)
Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes.
Nat Clin Pract Endocrinol Metab., Jan;3(1):46-56 (2007)
Regulation of vascular endothelial growth factor expression and vascularization in the myocardium by insulin receptor and PI3K/Akt pathways in insulin resistance and ischemia.
Arterioscler. Thromb. Vasc. Biol., Apr;26(4):787-93 (2006)
Molecular targets of diabetic cardiovascular complications.
Curr Drug Targets., Jun;6(4):487-94 (2005)
Protein kinase C activation and its pharmacological inhibition in vascular disease.
Vasc Med., 5(3):173-85 (2000)
Human vascular smooth muscle cells of diabetic origin exhibit increased proliferation, adhesion, and migration.
J. Vasc. Surg., Mar;33(3):601-7 (2001)
Diabetes Mellitus and its Complications in Asian Americans.
Asian Am Pac Isl J Health., 7(2):170-175 (1999)
Can protein kinase C inhibition and vitamin E prevent the development of diabetic vascular complications?
Diabetes Res. Clin. Pract., Sep;45(2-3):169-82 (1999)